Lv7
4330 积分 2021-09-07 加入
Condensed vs. Standard Step‐Up Dosing Schedule of Talquetamab in Relapsed/Refractory Multiple Myeloma
17小时前
已完结
Ivonescimab and other anti-programmed death-1/ligand 1 (PD-(L)1)/vascular endothelial growth factor (VEGF) bispecific antibodies: progress and prospects in cancer therapy
17小时前
已完结
A Patent Review on FDA‐Approved Antibody‐Drug Conjugates, Their Linkers and Drug Payloads
18小时前
已完结
An update on patent issues regarding antibody-drug conjugates
18小时前
待确认
An Update on Patent issues regarding Antibody Drug Conjugates
19小时前
已完结
Target identification and assessment in the era of AI
1天前
已完结
Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
6天前
已完结
Pharmacokinetics and Pharmacodynamics of Bimagrumab (BYM338)
6天前
已完结
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
7天前
已完结
Once-daily oral icotrokinra versus placebo and once-daily oral deucravacitinib in participants with moderate-to-severe plaque psoriasis (ICONIC-ADVANCE 1 & 2): two phase 3, randomised, placebo-controlled and active-comparator-controlled trials
7天前
已完结
皖公网安备34019202002308
